A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China
Clinical trial NCT05896774 · COMPLETED
Trial details
- NCT number
- NCT05896774
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2024-11-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.